Literature DB >> 3166729

Latent sensitization to apomorphine following repeated low doses.

B A Mattingly1, J E Gotsick, K Salamanca.   

Abstract

In two experiments, the effect of repeated injections of apomorphine on locomotor activity of rats was determined. In each experiment, different groups of rats were injected with either apomorphine (0.2, 1.0, or 5.0 mg/kg) or vehicle at either 24 or 72 hr intervals and tested for locomotor activity in photocell arenas. In Experiment 2, following 13 treatment sessions with various doses, all groups were first tested for activity following a 5.0 mg/kg dose of apomorphine and then given vehicle only prior to the final activity test session. Major findings were as follows: (a) repeated injections of 1.0 and 5.0 mg/kg apomorphine produced a progressively greater increase in activity with each injection (i.e., sensitization); (b) injections of 0.2 mg/kg of apomorphine produced a slight inhibition of activity, which did not change with repeated injections; (c) prior treatment with 0.2 mg/kg of apomorphine resulted in a significantly greater activity increase following a 5.0 mg/kg dose of apomorphine than did prior vehicle treatments; and (d) chronic pretreatment of rats with apomorphine did not affect their activity level following a vehicle injection. These findings suggest that sensitization to apomorphine is a graded, rather than an all or none, phenomenon dependent on the dose of apomorphine repeatedly administered. In addition, these results are inconsistent with autoreceptor tolerance and conditioning explanations of dopamine agonist-induced sensitization effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166729     DOI: 10.1037//0735-7044.102.4.553

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  11 in total

1.  Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections.

Authors:  D C Hoffman; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.

Authors:  B A Mattingly; J K Rowlett; J T Graff; B J Hatton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Effects of single and repeated exposure to apomorphine on the acoustic startle reflex and its inhibition by a visual prepulse.

Authors:  M K Taylor; J R Ison; S B Schwarzkopf
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

4.  Sensitization to apomorphine in pigeons: unaffected by latent inhibition but still due to classical conditioning.

Authors:  B Wynne; J D Delius
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

5.  Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.

Authors:  D C Hoffman; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

Authors:  J Stewart; J P Druhan
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.

Authors:  J B Bedingfield; L D Calder; R Karler
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

8.  Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride.

Authors:  Flávia Regina Cruz Dias; Robert J Carey; Marinete Pinheiro Carrera
Journal:  Psychopharmacology (Berl)       Date:  2010-02-23       Impact factor: 4.530

9.  Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists.

Authors:  S A McDougall; M A Duke; C A Bolanos; C A Crawford
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

10.  Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.

Authors:  B A Mattingly; J K Rowlett; G Lovell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.